Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists

European Journal of Pharmacology

Volumn 564, Issue 1-3, 2007, Pages 88-93

  Raffa, Robert B ^a   Cavallo, Federica ^b   Capasso, Anna ^b  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Benzodiazepine; Flumazenil; Physical dependence; Planaria; Withdrawal; Zolpidem

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CLORAZEPATE; FLUMAZENIL; MIDAZOLAM; ZOLPIDEM;

ABSTINENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG WITHDRAWAL; NONHUMAN; PRIORITY JOURNAL; TURBELLARIA;

ANALYSIS OF VARIANCE; ANIMALS; BENZODIAZEPINES; CLORAZEPATE DIPOTASSIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; GABA AGONISTS; GABA MODULATORS; LOCOMOTION; MIDAZOLAM; PLANARIANS; PYRIDINES; RECEPTORS, GABA-A; REPRODUCIBILITY OF RESULTS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 34250620563     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.006     Document Type: Article

References (35)

1. Algeri S., Carolei A., Ferretti P., Gallone C., Palladini G., and Venturini G. Effects of dopaminergic agents on monoamine levels and motor behaviour in Planaria. Comp. Biochem. Physiol. 74C (1983) 27-29
2. Bamber B.A., Twyman R.E., and Jorgensen E.M. Pharmacological characterization of the homomeric and heteromeric UNC-49 GABA receptors in C. elegans. Br. J. Pharmacol. 138 (2003) 883-893
3. A receptors drastically alter the affinity for ligands of the benzodiazepine binding site. J. Biol. Chem. 272 (1997) 11799-11804
4. Bateson A.N. Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr. Pharm. Des. 8 (2002) 5-21
5. Begg D.P., Hallam K.T., and Norman T.R. Attenuation of benzodiazepine withdrawal anxiety in the rat by serotonin antagonists. Behav. Brain Res. 161 (2005) 286-290
6. Carolei A., Margotta V., and Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Neuropsychobiology 1 (1975) 355-364
7. Frey H.H., and Scherkl R. Clorazepate, correlation between metabolism and anticonvulsant activity. Eur. J. Pharmacol. 158 (1988) 213-216
8. A-type agonist recognition site. Br. J. Pharmacol. 98 (1989) 841-850
9. Kaminski B.J., Sannerud C.A., Weerts E.M., Lamb R.J., and Griffiths R.R. Physical dependence in baboons chronically treated with low and high doses of diazepam. Behav. Pharmacol. 14 (2003) 331-342
10. Listos J., Malec D., and Fidecka S. Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice. Eur. J. Pharmacol. 523 (2005) 71-78
11. McNicholas L.F., Martin W.R., and Cherian S. Physical dependence on diazepam and lorazepam in the dog. J. Pharmacol. Exp. Ther. 226 (1983) 783-789
12. Möhler H., and Okada T. Benzodiazepine receptor: demonstration in the central nervous system. Science 198 (1977) 849-851
13. Palladini G., Ruggieri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in Planaria. Comp. Biochem. Physiol. C 115 (1996) 41-45
14. Passarelli F., Merante A., Pontieri F.E., Margotta V., Venturini G., and Palladini G. Opioid-dopamine interaction in Planaria: a behavioral study. Comp. Biochem. Physiol. C 124 (1999) 51-55
15. Pokk P., and Zharkovsky A. Small platform stress attenuates the anxiogenic effect of diazepam withdrawal in the plus-maze test. Behav. Brain Res. 97 (1998) 153-157
16. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res. 1032 (2005) 200-202
17. Raffa R.B., and Martley A.F. Amphetamine-induced increase in planarian locomotor activity and block by UV light. Brain Res. 1031 (2005) 138-140
18. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur. J. Pharmacol. 430 (2001) 143-145
19. Raffa R.B., Valdez J.M., Holland L.J., and Schulingkamp R.J. Energy-dependent UV light-induced disruption of (-)sulpiride antagonism of dopamine. Eur. J. Pharmacol. 406 (2000) R11-R12
20. Raffa R.B., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J. Pharmacol. Toxicol. Methods 45 (2001) 223-226
21. Raffa R.B., Stagliano G.W., and Umeda S. κ-Opioid withdrawal in Planaria. Neurosci. Lett. 349 (2003) 139-142
22. Raffa R.B., Dasrath C.S., and Brown D.R. Disruption of a drug-induced choice behavior by UV light. Behav. Pharmacol. 14 (2003) 569-571
23. Raffa R.B., Brown D.R., and Dasrath C.S. Cocaine effect on light/dark choice in Planaria: withdrawal. Pharmacologyonline 1 (2005) 67-77
24. Raffa R.B., Stagliano G.W., and Tallarida R.J. Subadditive withdrawal from cocaine/κ-opioid agonist combinations in Planaria. Brain Res. 1114 (2006) 31-35
25. Rawls S.M., Gomez T., Stagliano G.W., and Raffa R.B. Measurement of glutamate and aspartate in Planaria. J. Pharmacol. Toxicol. Methods 53 (2006) 291-295
26. Rawls S.M., Rodriguez T., Baron D.A., and Raffa R.B. A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res. 1099 (2006) 82-87
27. Rosenberg H.C., and Chiu T.H. An antagonist-induced benzodiazepine abstinence syndrome. Eur. J. Pharmacol. 81 (1982) 153-157
28. Rosenberg H.C., and Chiu T.H. Time course for development of benzodiazepine tolerance and physical dependence. Neurosci. Biobehav. Rev. 9 (1985) 123-131
29. Ryan G.P., and Boisse N.R. Experimental induction of benzodiazepine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 226 (1983) 100-107
30. Saitoh O., Yuruzume E., and Nakata H. Identification of planarian serotonin receptor by ligand binding and PCR studies. NeuroReport 8 (1996) 173-178
31. Umeda S., Stagliano G.W., and Raffa R.B. Cocaine and κ-opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Res. 1018 (2004) 181-185
32. Umeda S., Stagliano G.W., Borenstein M.R., and Raffa R.B. A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J. Pharmacol. Toxicol. Methods 51 (2005) 73-76
33. Venturini G., Carolei A., Palladini G., Margotta V., and Lauro M.G. Radioimmunological and immunocytochemical demonstration of Met-enkephalin in Planaria. Comp. Biochem. Physiol. 74 (1983) 23-25
34. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., and Palladini G. A pharmacological study of dopaminergic receptor in Planaria. Neuropharmacology 28 (1989) 1377-1382
35. Welsh J.H., and Williams L.D. Monoamine containing neurons in Planaria. J. Comp. Neurol. 138 (1970) 103-116